Literature DB >> 8499488

Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.

J P Vanden Heuvel1, P F Sterchele, D J Nesbit, R E Peterson.   

Abstract

Acyl-CoA binding protein (ACBP) and fatty acid binding protein (FABP) are important intracellular lipid binding proteins. The purpose of the present experiments was to test the hypothesis that peroxisome proliferators induce ACBP in rat hepatocytes as has been shown previously for FABP. The effects of two structurally dissimilar peroxisome proliferators perfluorodecanoic acid (PFDA) and clofibric acid (CPIB) were examined in primary rat hepatocyte cultures in a chemically defined media. Both compounds alter lipid metabolism in primary rat hepatocytes in a similar fashion, although PFDA is more potent than CPIB at inducing peroxisomal beta-oxidation. In addition, PFDA and CPIB compete with long-chain fatty acids for binding to FABP but do not compete with long-chain acyl-CoA esters for binding to ACBP. The concentration of ACBP and FABP was increased in peroxisome proliferator-treated hepatocytes relative to vehicle controls within 48 h of treatment. Evidence is given to support increases in ACBP and FABP mRNA being the cause of the increased protein levels by peroxisome proliferators. In addition, the peroxisome proliferators PFDA, perfluorooctanoic acid and ciprofibrate induced hepatic ACBP following in vivo administration to rats indicating that this phenomena is not exclusive to in vitro systems. Therefore, ACBP appears to be a member of the peroxisome proliferator loci, a group of lipid metabolizing proteins, including FABP, which are regulated by peroxisome proliferators such as fibric acids and perfluorinated fatty acids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499488     DOI: 10.1016/0167-4889(93)90039-r

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

2.  Perfluorodecanoic acid enhances the formation of oleic acid in rat liver.

Authors:  A Yamamoto; Y Kawashima
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

3.  Biosynthesis of medium-chain triacylglycerols and phospholipids by HepG-2 cells.

Authors:  R Pakula; M Rubin; A M Moser; D Lichtenberg; A Tietz
Journal:  Lipids       Date:  1997-05       Impact factor: 1.880

4.  Overexpression of acyl-coA binding protein and its effects on the flux of free fatty acids in McA-RH 7777 cells.

Authors:  Y Yang; P H Pritchard; J Bhuiyan; D W Seccombe; M H Moghadasian
Journal:  Lipids       Date:  2001-06       Impact factor: 1.880

5.  Conjugated linoleic acid modulates hepatic lipid composition in mice.

Authors:  M A Belury; A Kempa-Steczko
Journal:  Lipids       Date:  1997-02       Impact factor: 1.880

6.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

7.  High dietary fat exacerbates weight gain and obesity in female liver fatty acid binding protein gene-ablated mice.

Authors:  Barbara P Atshaves; Avery L McIntosh; Stephen M Storey; Kerstin K Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2009-12-25       Impact factor: 1.880

8.  Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.

Authors:  Lei Guo; Hong Fang; Jim Collins; Xiao-hui Fan; Stacey Dial; Alex Wong; Kshama Mehta; Ernice Blann; Leming Shi; Weida Tong; Yvonne P Dragan
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.